Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis
Clinical trial NCT04360187 · COMPLETED
Trial details
- NCT number
- NCT04360187
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2021-09-08
- Enrollment
- 391
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.